Tag: Atrial Fibrillation

Older age was also an independent risk factor for ventricular ectopic burden; lower eGFR linked to high AEB, VEB

Biomarkers improve CHA2DS2-VASc model fit and predictive ability, with NTproBNP and GDF-15 yielding the best fit

While no difference in mortality observed, benefits seen for atrial fibrillation symptom severity, frequency

Increase in primary end point of death, heart failure hospitalization seen in association with baseline AF for patients undergoing M-TEER

Surgical ablation reduces relative risks for ischemic stroke, stroke from any cause, but benefits uncertain for other outcomes

Medicare beneficiaries undergoing concomitant surgical ablation have risk-adjusted median survival advantage

Findings show enhanced precision in identifying termination sites in patients with persistent atrial fibrillation

Findings seen for all cardiac arrhythmias, including atrial fibrillation

One-year stroke risk was 0.7 and 1.8 percent for patients with CHA2DS2-VA scores of 1 to 4 and 5 to 8

Significant dose-effect seen between flossing frequency and reduction in incident ischemic stroke